• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,319.55 185.23
( 0.25%)
Global Indices
Nasdaq
46,525.67 -61.07
(-0.13%)
Dow Jones
6,603.69 7.37
(0.11%)
Hang Seng
53,162.49 699.22
(1.33%)
Nikkei 225
10,436.29 71.50
(0.69%)
Forex
USD-INR
93.17 -0.69
(-0.73%)
EUR-INR
107.97 0.00
(0.00%)
GBP-INR
123.80 -0.23
(-0.19%)
JPY-INR
0.59 0.00
(-0.32%)

EQUITY - MARKET SCREENER

Bal Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524824
INE083D01012
62.7662681
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BALPHARMA
11.77
101.91
EPS(TTM)
Face Value()
Div & Yield %
5.44
10
1.87
 

Sayaji Hotels inks pact with Om Shivam Buildcon for Nagpur property
Nov 18,2025
According to an exchange filing, Sayaji Hotels will manage and operate a 4-star hotel owned by Om Shivam Buildcon, located in Hingna, Nagpur, Maharashtra. The property will feature 115 rooms, two banquet halls, two restaurants, two boardrooms, a gym, and a spa. The hotel will operate under the brand name “Effotel by Sayaji.”

The agreement is set for a tenure of 15 years from the date of the hotel’s commercial launch, with an option for renewal in five-year increments on mutually agreed terms.

Sayaji Hotels is primarily engaged in the business of owning, operating & managing hotels.

The company reported a consolidated net loss of Rs 9.85 crore in Q2 FY26 as against Rs 1.30 crore posted in Q2 FY25. However, revenue from operations jumped 12.6% YoY to Rs 31.67 crore in the quarter ended 30 September 2025.

The counter declined 1.43% to Rs 286.30 on the BSE.